BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17985233)

  • 1. Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells.
    Guo JT; Chen AQ; Kong Q; Zhu H; Ma CM; Qin C
    Cell Mol Neurobiol; 2008 Jan; 28(1):35-47. PubMed ID: 17985233
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    El-Habta R; Af Bjerkén S; Virel A
    Neurol Res; 2024 May; 46(5):406-415. PubMed ID: 38498979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
    Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
    Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference targeting α-synuclein attenuates methamphetamine-induced neurotoxicity in SH-SY5Y cells.
    Chen L; Huang E; Wang H; Qiu P; Liu C
    Brain Res; 2013 Jul; 1521():59-67. PubMed ID: 23688541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenpropathrin, a Widely Used Pesticide, Causes Dopaminergic Degeneration.
    Xiong J; Zhang X; Huang J; Chen C; Chen Z; Liu L; Zhang G; Yang J; Zhang Z; Zhang Z; Lin Z; Xiong N; Wang T
    Mol Neurobiol; 2016 Mar; 53(2):995-1008. PubMed ID: 25575680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans.
    Cao P; Yuan Y; Pehek EA; Moise AR; Huang Y; Palczewski K; Feng Z
    PLoS One; 2010 Feb; 5(2):e9312. PubMed ID: 20174477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release.
    Ganapathy K; Datta I; Sowmithra S; Joshi P; Bhonde R
    J Cell Biochem; 2016 Dec; 117(12):2719-2736. PubMed ID: 27064513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
    Park SS; Schulz EM; Lee D
    Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons.
    Ulusoy A; Björklund T; Buck K; Kirik D
    Neurobiol Dis; 2012 Sep; 47(3):367-77. PubMed ID: 22659302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells.
    Watabe M; Nakaki T
    Mol Pharmacol; 2008 Oct; 74(4):933-40. PubMed ID: 18599602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons.
    Fountaine TM; Venda LL; Warrick N; Christian HC; Brundin P; Channon KM; Wade-Martins R
    Eur J Neurosci; 2008 Dec; 28(12):2459-73. PubMed ID: 19032594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
    Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
    Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.
    Feng LR; Maguire-Zeiss KA
    Neurotox Res; 2011 Nov; 20(4):387-401. PubMed ID: 21735318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells.
    Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S
    Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
    Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells.
    Bisaglia M; Greggio E; Maric D; Miller DW; Cookson MR; Bubacco L
    BMC Neurosci; 2010 Mar; 11():41. PubMed ID: 20334701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moracenin D from Mori Cortex radicis protects SH-SY5Y cells against dopamine-induced cell death by regulating nurr1 and α-synuclein expression.
    Ham A; Lee HJ; Hong SS; Lee D; Mar W
    Phytother Res; 2012 Apr; 26(4):620-4. PubMed ID: 21936000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
    Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
    Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.